Table 2.

Multivariate analysis of factors associated with post LT HCC recurrence in men and women.

Covariate	Men HR (95% CI)	p value	Women HR (95% CI)	p value
African American (AA) vs. non-AA	0.77 (0.48–1.24)	0.28	0.20 (0.03–1.44)	0.11
Alcohol vs. hepatitis C (HCV)*	0.19 (0.07–0.52)	0.001	0.97 (0.29–3.22)	0.96
Waitlist time > 120 days	0.53 (0.33–0.86)	0.01	0.52 (0.23–1.21)	0.13
Tumor Burden at LT (ref > 1 tumor, all < 2 cm):
1 tumor ≥ 2 cm	1.45 (0.96–2.18)	0.08	2.33 (0.93–5.9)	0.07
2–3 tumors ≥ 2 cm	1.62 (0.89–2.95)	0.12	2.43 (0.65–9.11)	0.19
Loco-regional therapy (LRT) vs.no LRT	1.24 (0.96–1.61)	0.09	2.28 (1.32–3.94)	0.003
Pre LT AFP 101–500 vs. ≤ 100	1.50 (1.06–2.13)	0.02	4.21 (2.17–8.18)	< 0.001

^*All disease etiologies were includedin the model using HCV as reference, with risk difference only identifiedin alcohol versus HCVamong men.